share_log
Reuters ·  Mar 18 10:07
Onkure Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $34 From $40
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 376

Recommended

Write a comment